GlassScriptPhysician profile
Frank N Hrisomalos
NPI 1003106824
$3,548.24
in general payments reported to CMS, 2019-2025
17 companies · $2,127 in 2025
The $2,127 reported for 2025 was more than what 83% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $30.41 · 2021: $119 · 2022: $169 · 2023: $558 · 2024: $404 · 2025: $2,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,423 · Travel and Lodging: $666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,422.66 |
| Travel and Lodging | $666.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Onmark, INC. | $1,315.10 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $500.44 | 2019-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $347.99 | 2023-2025 | Vabysmo, Susvimo |
| Astellas Pharma US INC | $293.05 | 2023-2025 | Izervay |
| US Oncology Corporate, INC. | $202.27 | 2025 | |
| Harrow Eye, LLC | $148.29 | 2025 | Iheezo, Triesence |
| Alimera Sciences, INC. | $129.60 | 2019-2023 | Iluvien |
| Apellis Pharmaceuticals, INC. | $129.51 | 2022-2025 | Syfovre |
| Eyepoint US, INC. | $102.37 | 2023 | |
| Alcon Vision LLC | $95.88 | 2021-2022 | |
| Amgen INC. | $91.39 | 2025 | Pavblu |
| Ani Pharmaceuticals, INC. | $67.33 | 2025 | Iluvien, Yutiq |
| Allergan, INC. | $30.40 | 2020-2022 | |
| Coopervision INC. | $25.65 | 2022 | |
| Rxsight INC | $23.46 | 2023 | Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal), Rxsight Light Delivery Device (Ldd) |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $23.23 | 2021 | |
| Aerie Pharmaceuticals, INC. | $22.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Hrisomalos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.